Association Between Transient Opioid Use and Short-Term Respiratory Exacerbation Among Adults With Chronic...

Area of Science:

• Pulmonary Medicine
• Pharmacology
• Health Services Research

Background:

• Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality.
• Opioid use is common, but its association with COPD exacerbations is not well understood.
• Previous research has focused on historical opioid use, not short-term exposure.

Purpose of the Study:

• To examine the association between transient or short-term opioid use and acute respiratory exacerbations in adult COPD patients.
• To quantify the risk of exacerbations associated with specific opioid doses.

Main Methods:

• Case-crossover design using Mississippi Medicaid administrative claims data (2013-2017).
• Analyzed 1,972 exacerbation events in 1,354 beneficiaries.
• Compared opioid exposure in the 7 days before exacerbation to 10 control periods.
• Adjusted for concurrent use of bronchodilators, corticosteroids, benzodiazepines, and beta-blockers.

Main Results:

• Opioid exposure within 7 days before an exacerbation was significantly associated with acute respiratory exacerbation (OR = 1.81).
• Each 25-mg increase in morphine equivalent daily dose increased exacerbation odds by 11.2% (OR = 1.11).
• Transient opioid use showed a significant association with COPD acute respiratory exacerbation.

Conclusions:

• Transient opioid use is a significant risk factor for acute respiratory exacerbations in COPD patients.
• Opioid prescribing for COPD patients should be approached with caution due to increased exacerbation risk.
• Further research is needed to explore the mechanisms and long-term implications.